Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Enterprise Value: 2021

Historic Enterprise Value for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $14.5 million.

  • Cardiol Therapeutics' Enterprise Value fell 54.92% to $75.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$56.1 million, marking a year-over-year decrease of 131.47%. This contributed to the annual value of $14.5 million for FY2021, which is N/A change from last year.
  • Cardiol Therapeutics' Enterprise Value amounted to $14.5 million in FY2021.
  • In the past 5 years, Cardiol Therapeutics' Enterprise Value ranged from a high of $14.5 million in FY2021 and a low of $14.5 million during FY2021.
  • For the 1-year period, Cardiol Therapeutics' Enterprise Value averaged around $14.5 million, with its median value being $14.5 million (2021).